• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma USA 2023: Conversational AI

Article

In this interview, Arun Thachi, Director, Head of IT Marketing and Sales, Boehringer Ingelheim, discusses the AI journey in pharma.

Arun Thachi, Director, Head of IT Marketing and Sales, Boehringer Ingelheim, explains conversational AI and how it can be best-used in pharma to inform and engage.

Recent Videos
Related Content
Gaugarin Oliver

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver
November 19th 2024
Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan
November 15th 2024
Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle
November 14th 2024
Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Abby Reynolds

The Rise of Digital Platforms: Q&A with Abby Reynolds

Mike Hollan
November 14th 2024
Article

Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Don Tracy, Associate Editor
November 8th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.